Email updates

Keep up to date with the latest news and content from HQLO and BioMed Central.

Open Access Commentary

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company

Fabio Arpinelli* and Francesco Bamfi

Health and Quality of Life Outcomes 2006, 4:85  doi:10.1186/1477-7525-4-85

Article Metrics

8127
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 44 accesses
  • Last 365 days: 893 accesses
  • All time: 8127 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information